174 related articles for article (PubMed ID: 31813023)
41. Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.
Mühe J; Wang F
PLoS Pathog; 2017 Dec; 13(12):e1006772. PubMed ID: 29261800
[TBL] [Abstract][Full Text] [Related]
42. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
Tierney RJ; Kao KY; Nagra JK; Rickinson AB
J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth.
Tobollik S; Meyer L; Buettner M; Klemmer S; Kempkes B; Kremmer E; Niedobitek G; Jungnickel B
Blood; 2006 Dec; 108(12):3859-64. PubMed ID: 16882707
[TBL] [Abstract][Full Text] [Related]
44. The CR4 region of EBNA2 confers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling.
Grabusic K; Maier S; Hartmann A; Mantik A; Hammerschmidt W; Kempkes B
J Gen Virol; 2006 Nov; 87(Pt 11):3169-3176. PubMed ID: 17030849
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
Murakami M; Lan K; Subramanian C; Robertson ES
J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
[TBL] [Abstract][Full Text] [Related]
46. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.
Cooper A; Johannsen E; Maruo S; Cahir-McFarland E; Illanes D; Davidson D; Kieff E
J Virol; 2003 Jan; 77(2):999-1010. PubMed ID: 12502816
[TBL] [Abstract][Full Text] [Related]
47. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
Zimber-Strobl U; Strobl LJ
Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604
[TBL] [Abstract][Full Text] [Related]
48. Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.
Lucchesi W; Brady G; Dittrich-Breiholz O; Kracht M; Russ R; Farrell PJ
J Virol; 2008 Aug; 82(15):7456-66. PubMed ID: 18480445
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
[TBL] [Abstract][Full Text] [Related]
50. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
51. The Effects of Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) on B-Lymphocytic Activity.
Qu M; Ding F; Di S; Zhang S; Yu X
Clin Lab; 2018 Apr; 64(4):425-431. PubMed ID: 29739075
[TBL] [Abstract][Full Text] [Related]
52. A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth.
Wang C; Liu X; Liang J; Narita Y; Ding W; Li D; Zhang L; Wang H; Leong MML; Hou I; Gerdt C; Jiang C; Zhong Q; Tang Z; Forney C; Kottyan L; Weirauch MT; Gewurz BE; Zeng MS; Jiang S; Teng M; Zhao B
Nat Commun; 2023 Mar; 14(1):1598. PubMed ID: 36949074
[TBL] [Abstract][Full Text] [Related]
53. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
[TBL] [Abstract][Full Text] [Related]
54. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
Beer S; Wange LE; Zhang X; Kuklik-Roos C; Enard W; Hammerschmidt W; Scialdone A; Kempkes B
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2200512119. PubMed ID: 35857872
[TBL] [Abstract][Full Text] [Related]
55. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
[TBL] [Abstract][Full Text] [Related]
56. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.
Gordadze AV; Peng R; Tan J; Liu G; Sutton R; Kempkes B; Bornkamm GW; Ling PD
J Virol; 2001 Jul; 75(13):5899-912. PubMed ID: 11390591
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.
Wang LW; Wang Z; Ersing I; Nobre L; Guo R; Jiang S; Trudeau S; Zhao B; Weekes MP; Gewurz BE
PLoS Pathog; 2019 Sep; 15(9):e1008030. PubMed ID: 31518366
[TBL] [Abstract][Full Text] [Related]
58. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
Dudziak D; Kieser A; Dirmeier U; Nimmerjahn F; Berchtold S; Steinkasserer A; Marschall G; Hammerschmidt W; Laux G; Bornkamm GW
J Virol; 2003 Aug; 77(15):8290-8. PubMed ID: 12857898
[TBL] [Abstract][Full Text] [Related]
59. Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
Kohlhof H; Hampel F; Hoffmann R; Burtscher H; Weidle UH; Hölzel M; Eick D; Zimber-Strobl U; Strobl LJ
Blood; 2009 May; 113(22):5506-15. PubMed ID: 19339697
[TBL] [Abstract][Full Text] [Related]
60. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.
Zhao B; Maruo S; Cooper A; R Chase M; Johannsen E; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1900-5. PubMed ID: 16446431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
